GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (FRA:978) » Definitions » Beginning Cash Position

Adagene (FRA:978) Beginning Cash Position : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Adagene Beginning Cash Position?

Adagene's Beginning Cash Position for the quarter that ended in Jun. 2024 was €0.00 Mil.

Adagene's annual Beginning Cash Position increased from Dec. 2021 (€66.51 Mil) to Dec. 2022 (€164.63 Mil) but then declined from Dec. 2022 (€164.63 Mil) to Dec. 2023 (€131.83 Mil).

Adagene Beginning Cash Position Historical Data

The historical data trend for Adagene's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagene Beginning Cash Position Chart

Adagene Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 14.45 76.06 66.51 164.63 131.83

Adagene Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Adagene Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Adagene Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Adagene's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Adagene Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (FRA:978) » Definitions » Beginning Cash Position
Comparable Companies
CRVS FIXX OCEA ASMB IOBT HCWB ANEB ALGS ANVS ACET OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ADAG:USA
Address
Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123
Website
https://www.adagene.com
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Adagene Headlines

No Headlines